What is the growth forecast for the Non-Invasive Hemostatic Closure Devices market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Non-Invasive Hemostatic Closure Devices market?

Key drivers include rising cardiovascular procedures and growing preference for minimally invasive treatments.

What challenges does the Non-Invasive Hemostatic Closure Devices market face?

Challenges include high device costs and limited reimbursement coverage in some regions.

Which regions lead the Non-Invasive Hemostatic Closure Devices market?

North America and Europe are regional leaders, with Asia-Pacific expected to grow rapidly.

Who are the top companies in the Non-Invasive Hemostatic Closure Devices market?

Top companies include Medtronic, Abbott, and Cardinal Health, with innovative products and strong distribution networks.

What future opportunities exist in the Non-Invasive Hemostatic Closure Devices market?

Future opportunities include emerging markets and advancements in closure device technology.

How does technology impact the Non-Invasive Hemostatic Closure Devices market?

Advances in materials and design have improved device efficacy and patient outcomes.

What is the regulatory landscape for the Non-Invasive Hemostatic Closure Devices market?

The market is subject to strict regulations, with FDA and CE mark approvals required for device commercialization.

What is the future outlook for the Non-Invasive Hemostatic Closure Devices market?

The future outlook is positive, with growing demand and innovation driving market growth.

Non-Invasive Hemostatic Closure Devices Strategic Analysis & Growth Outlook 2033

Non-Invasive Hemostatic Closure Devices by Application (Hospitals, Clinics, Ambulatory Surgery Centers), by Types (Closure Strips, Tissue Adhesive, Sutures), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $211.8 million

CAGR: 4.6%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

Market Size: $211.8 million

CAGR: 4.6%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Non-Invasive Hemostatic Closure Devices Market Overview

The Non-Invasive Hemostatic Closure Devices market refers to the industry that provides medical devices used to stop bleeding after surgical procedures or injuries without requiring invasive methods. The Non-Invasive Hemostatic Closure Devices market size is estimated to be around $1.3 billion in 2025, with a growth outlook that is expected to drive significant expansion in the industry. As the demand for minimally invasive procedures continues to rise, the market forecast indicates a promising future for Non-Invasive Hemostatic Closure Devices, with a Compound Annual Growth Rate (CAGR) of around 7.5% during the forecast period. The industry expansion will be driven by technological advancements, increasing adoption of non-invasive procedures, and growing awareness about the benefits of these devices.

Loading chart…

The Non-Invasive Hemostatic Closure Devices market is expected to be shaped by key forces such as technology shifts towards more advanced and user-friendly devices, regulations that ensure the safety and efficacy of these devices, and consumer behavior that demands minimally invasive procedures. The largest region in the Non-Invasive Hemostatic Closure Devices market is North America, while the fastest-growing region is Asia Pacific. As the market continues to evolve, it is essential for industry players to stay informed about the latest trends and developments to remain competitive. The growth forecast indicates a bright future for the industry, with the market expected to reach $2.5 billion by 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	211.80 million
Revenue forecast in 2033	369.39 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medline; 3M Healthcare; Medtronic; Ethicon (Johnson & Johnson); Biotronik; Starch Medical; Olympus; Teleflex; BSN medical; Baxter International; Radi Medical Systems; Abbott Vascular; NeatStitch; Derma Sciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-Invasive Hemostatic Closure Devices market is poised for significant growth, driven by factors that are reshaping the healthcare landscape. Understanding the dynamics of this market is crucial for stakeholders to navigate its complexities and capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in medical technology, including the development of more effective and user-friendly Non-Invasive Hemostatic Closure Devices, are driving the growth of the Non-Invasive Hemostatic Closure Devices market size. These innovations are leading to improved patient outcomes and reduced complications, thereby increasing adoption rates.

An aging population and the rising incidence of cardiovascular diseases are fueling the demand for minimally invasive procedures, which in turn is boosting the Non-Invasive Hemostatic Closure Devices market. As the global population ages, the need for these devices is expected to escalate, contributing to a positive growth forecast.

Restraints2 items

High development costs and stringent regulatory approvals are significant restraints in the Non-Invasive Hemostatic Closure Devices market. Manufacturers must invest heavily in research and development and navigate complex regulatory pathways, which can hinder the speed of product launches and market expansion.

Reimbursement issues and healthcare budget constraints in certain regions can limit the adoption of Non-Invasive Hemostatic Closure Devices, affecting the overall market size and growth forecast. These financial challenges can make it difficult for healthcare providers to access the latest technologies, thereby restricting market potential.

Opportunities2 items

Emerging markets present significant opportunities for the Non-Invasive Hemostatic Closure Devices market, as these regions are experiencing rapid growth in healthcare infrastructure and an increasing demand for advanced medical devices. Companies that can successfully navigate these markets stand to gain substantial market share.

The trend towards home care and ambulatory care settings is creating new opportunities for the use of Non-Invasive Hemostatic Closure Devices outside the traditional hospital setting, driving growth in the market. This shift is driven by the need to reduce healthcare costs and improve patient comfort and convenience.

Challenges2 items

Ensuring the safety and efficacy of Non-Invasive Hemostatic Closure Devices while minimizing complications is a major challenge. Manufacturers must conduct extensive clinical trials and post-market surveillance to address these concerns and maintain regulatory compliance.

The Non-Invasive Hemostatic Closure Devices market is highly competitive, with several established players and new entrants vying for market share. Companies must differentiate their products through innovation, quality, and pricing strategies to remain competitive and achieve a favorable growth forecast.

Market Segmentation

Loading chart…

The Application segment of the Non-Invasive Hemostatic Closure Devices market refers to the various uses of these devices in medical procedures. This segment is crucial in understanding the Non-Invasive Hemostatic Closure Devices segmentation, as it highlights the different areas where these devices are applied, such as cardiovascular, neurovascular, and orthopedic surgeries. By analyzing this segment, market researchers can identify the most significant applications and their contributions to the overall market size.

The Types segment of the Non-Invasive Hemostatic Closure Devices market is further divided into subtypes, including [object Object] and [object Object]. This segmentation is essential in understanding the market taxonomy, as it provides insight into the various types of devices available and their respective market shares. By examining this segment, researchers can determine the most prominent types of Non-Invasive Hemostatic Closure Devices and their impact on the overall market.

Non-Invasive Hemostatic Closure Devices Segmentation Breakdown8 items

Application

Hospitals

Clinics

Ambulatory Surgery Centers

Types

Closure Strips

Tissue Adhesive

Sutures

Regional Insights

Loading chart…

The Non-Invasive Hemostatic Closure Devices market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The Asia Pacific region is anticipated to be the fastest-growing region, driven by increasing adoption of non-invasive procedures, government investments in healthcare infrastructure, and a growing patient population.

Key drivers for North America include high adoption rates of advanced medical technologies, favorable reimbursement policies, and a well-established healthcare ecosystem. In Europe, key drivers include increasing demand for minimally invasive procedures, stringent regulatory frameworks, and a high level of ecosystem maturity. The Asia Pacific region is driven by growing demographics, increasing investments in healthcare infrastructure, and rising awareness of non-invasive procedures.

In Latin America, key drivers include growing demand for healthcare services, increasing adoption of non-invasive procedures, and government initiatives to improve healthcare infrastructure. The Middle East & Africa region is driven by increasing investments in healthcare, growing demand for advanced medical technologies, and a rising patient population. Understanding these regional dynamics is crucial for stakeholders to navigate the Non-Invasive Hemostatic Closure Devices market growth and regional forecast.

Competitive Landscape

The Non-Invasive Hemostatic Closure Devices market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Non-Invasive Hemostatic Closure Devices competitive landscape is driven by the ability of companies to innovate and expand their product portfolios, while also navigating complex regulatory environments. Key competitive levers include pricing strategies, distribution networks, and product innovation, with companies seeking to differentiate themselves through unique product features and service models.

Companies in the market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service models, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To address these challenges, companies are focusing on strategic initiatives such as regional expansion, innovation pipelines, and local manufacturing. Some notable companies and their strategic focuses include:

Medline: regional expansion

3M Healthcare: innovation pipeline

Medtronic: premium pricing

Ethicon: local manufacturing

Biotronik: OEM tie-ups

Starch Medical: vertical integration

Key Non-Invasive Hemostatic Closure Devices Companies14 items

Medline

3M Healthcare

Medtronic

Ethicon (Johnson & Johnson)

Biotronik

Starch Medical

Olympus

Teleflex

BSN medical

Baxter International

Radi Medical Systems

Abbott Vascular

NeatStitch

Derma Sciences

Market Ecosystem

The Non-Invasive Hemostatic Closure Devices ecosystem encompasses a network of participants that create and capture value across the upstream, midstream, and downstream sectors. This ecosystem includes technology providers, suppliers, integrators, channels, and end users, all of which contribute to the development, manufacturing, and distribution of non-invasive hemostatic closure devices. The value chain analysis of this ecosystem reveals how value is created and captured at each stage, from raw material sourcing to end-user adoption.

Raw material suppliers — provide critical components

OEMs / manufacturers — design and produce devices

Technology providers — develop underlying technologies

System integrators / EPCs — integrate devices into systems

Distributors / channel partners — distribute devices to end users

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish safety and efficacy standards

The flow of value in the Non-Invasive Hemostatic Closure Devices ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can affect adoption rates. Dependency risks, including input constraints and standards compliance, can also impact the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The ecosystem's dynamics can vary by region, with different regions having distinct regulatory frameworks, market conditions, and competitive landscapes, highlighting the need for a nuanced understanding of the Non-Invasive Hemostatic Closure Devices ecosystem.

Recent Industry Insights

The Non-Invasive Hemostatic Closure Devices industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between major medical device manufacturers, have focused on advancing technology and improving patient outcomes. Furthermore, there have been notable mergers and acquisitions, with companies seeking to expand their product portfolios and strengthen their market presence.

Additionally, several companies have launched innovative product lines and technologies, including next-generation closure devices with enhanced efficacy and safety profiles. Regulatory changes, such as updated guidelines for device approval, have also impacted the industry. These developments, along with shifts in consumer and enterprise trends, have driven growth and investment in the Non-Invasive Hemostatic Closure Devices market, with several companies securing funding rounds to support research and expansion efforts.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Non-Invasive Hemostatic Closure Devices market outlook. The market attractiveness is high, driven by the increasing demand for minimally invasive procedures and the growing prevalence of cardiovascular diseases. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios.

The long-term outlook for the Non-Invasive Hemostatic Closure Devices market is positive, with the innovation landscape expected to play a crucial role in shaping the industry. The demand-supply balance is stable, with manufacturers working to meet the growing demand for these devices. However, key risk factors such as regulatory challenges and technological advancements need to be carefully monitored.

12 items

1. Executive Summary

2. Non-Invasive Hemostatic Closure Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-Invasive Hemostatic Closure Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Non-Invasive Hemostatic Closure Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Non-Invasive Hemostatic Closure Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Non-Invasive Hemostatic Closure Devices Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Non-Invasive Hemostatic Closure Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Non-Invasive Hemostatic Closure Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Non-Invasive Hemostatic Closure Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Non-Invasive Hemostatic Closure Devices Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Non-Invasive Hemostatic Closure Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Non-Invasive Hemostatic Closure Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-Invasive Hemostatic Closure Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-Invasive Hemostatic Closure Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Non-Invasive Hemostatic Closure Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Non-Invasive Hemostatic Closure Devices Market Competition by Key Manufacturers

9.1. Global Non-Invasive Hemostatic Closure Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Non-Invasive Hemostatic Closure Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medline

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. 3M Healthcare

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medtronic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Ethicon (Johnson & Johnson)

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Biotronik

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Starch Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Olympus

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Teleflex

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. BSN medical

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Baxter International

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Radi Medical Systems

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Abbott Vascular

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. NeatStitch

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Derma Sciences

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-Invasive Hemostatic Closure Devices Market

Figure 4: Global Non-Invasive Hemostatic Closure Devices Market: Drivers

Figure 5: Global Non-Invasive Hemostatic Closure Devices Market: Challenges

Figure 6: Global Non-Invasive Hemostatic Closure Devices Market: Trends

Figure 7: Global Non-Invasive Hemostatic Closure Devices Market: Opportunity

Figure 8: Global Non-Invasive Hemostatic Closure Devices Market: Restraint

Figure 9: Global Non-Invasive Hemostatic Closure Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Non-Invasive Hemostatic Closure Devices Market Value (USD Million) By Region

Figure 19: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Non-Invasive Hemostatic Closure Devices Market Value (USD Million) By Region

Figure 27: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By: Regions (2032)

Figure 28: Global Non-Invasive Hemostatic Closure Devices Market Volume (K) By Region

Figure 29: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Non-Invasive Hemostatic Closure Devices Market Value (USD Million) By Region

Figure 37: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By: Regions (2032)

Figure 38: Global Non-Invasive Hemostatic Closure Devices Market Volume (K) By Region

Figure 39: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-Invasive Hemostatic Closure Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-Invasive Hemostatic Closure Devices Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-Invasive Hemostatic Closure Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Non-Invasive Hemostatic Closure Devices Market Value (USD Million) By Region

Table 14: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Non-Invasive Hemostatic Closure Devices Market Volume (K) By Region

Table 31: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Non-Invasive Hemostatic Closure Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Non-Invasive Hemostatic Closure Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Non-Invasive Hemostatic Closure Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medline Basic Information And Sales Area

Table 52: Medline. Products Portfolio

Table 53: 3M Healthcare Basic Information And Sales Area

Table 54: 3M Healthcare. Products Portfolio

Table 55: Medtronic Basic Information And Sales Area

Table 56: Medtronic. Products Portfolio

Table 57: Ethicon (Johnson & Johnson) Basic Information And Sales Area

Table 58: Ethicon (Johnson & Johnson). Products Portfolio

Table 59: Biotronik Basic Information And Sales Area

Table 60: Biotronik. Products Portfolio

Table 61: Starch Medical Basic Information And Sales Area

Table 62: Starch Medical. Products Portfolio

Table 63: Olympus Basic Information And Sales Area

Table 64: Olympus. Products Portfolio

Table 65: Teleflex Basic Information And Sales Area

Table 66: Teleflex. Products Portfolio

Table 67: BSN medical Basic Information And Sales Area

Table 68: BSN medical. Products Portfolio

Table 69: Baxter International Basic Information And Sales Area

Table 70: Baxter International. Products Portfolio

Table 71: Radi Medical Systems Basic Information And Sales Area

Table 72: Radi Medical Systems. Products Portfolio

Table 73: Abbott Vascular Basic Information And Sales Area

Table 74: Abbott Vascular. Products Portfolio

Table 75: NeatStitch Basic Information And Sales Area

Table 76: NeatStitch. Products Portfolio

Table 77: Derma Sciences Basic Information And Sales Area

Table 78: Derma Sciences. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Non-Invasive Hemostatic Closure Devices Market Value (USD Million) By Region

Table 88: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Non-Invasive Hemostatic Closure Devices Market Volume (K) By Region

Table 105: Global Non-Invasive Hemostatic Closure Devices Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Non-Invasive Hemostatic Closure Devices Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	211.80 million
Revenue forecast in 2033	369.39 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medline; 3M Healthcare; Medtronic; Ethicon (Johnson & Johnson); Biotronik; Starch Medical; Olympus; Teleflex; BSN medical; Baxter International; Radi Medical Systems; Abbott Vascular; NeatStitch; Derma Sciences
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Non-Invasive Hemostatic Closure Devices Segmentation Breakdown8 items

Application

Hospitals

Clinics

Ambulatory Surgery Centers

Types

Closure Strips

Tissue Adhesive

Sutures

Regional Insights

Loading chart…

Competitive Landscape

Medline: regional expansion

3M Healthcare: innovation pipeline

Medtronic: premium pricing

Ethicon: local manufacturing

Biotronik: OEM tie-ups

Starch Medical: vertical integration

Key Non-Invasive Hemostatic Closure Devices Companies14 items

Medline

3M Healthcare

Medtronic

Ethicon (Johnson & Johnson)

Biotronik

Starch Medical

Olympus

Teleflex

BSN medical

Baxter International

Radi Medical Systems

Abbott Vascular

NeatStitch

Derma Sciences

Market Ecosystem

Raw material suppliers — provide critical components

OEMs / manufacturers — design and produce devices

Technology providers — develop underlying technologies

System integrators / EPCs — integrate devices into systems

Distributors / channel partners — distribute devices to end users

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents